Taotlus tuleb esitada eraldi iga preparaadi kohta, sealhulgas kui tegemist on sama toimeainet sisaldavate erinevate ravimvormidega ja sama toimeainet erinevas koguses sisaldavate preparaatidega.
The basic fee should be defined as the fee charged for the initial application for an authorization for a medicinal product plus a fee for each different strength and/or pharmaceutical form; whereas, however, a ceiling should be established.
